Targeted alpha therapy using [Bi-213]Substance P overcomes chemo- and radioresistance in glioblastoma and glioblastoma stem cells

被引：0
|
作者：
Friesen, C. [1 ]
Hormann, I. [1 ]
Roscher, M. [1 ]
Morgenstern, A. [2 ]
Bruchertseifer, F. [2 ]
Maecke, H. [3 ]
Fulda, S. [4 ]
Apostolidis, C. [2 ]
Debatin, K. -M. [4 ]
Miltner, E. [1 ]
机构：
[1] Univ Ulm, Inst Rechts Med, Ulm, Germany
[2] Europa Kommiss, Inst Transurane, Karlsruhe, Germany
[3] Univ Freiburg, Freiburg, Germany
[4] Univ Ulm, Klin Kinder & Jugendmed, Ulm, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [1] Breaking radio- and chemoresistance in glioblastoma and glioblastoma-initiating-stem cells using [Bi-213]SubstanceP in targeted alpha-therapy
    Friesen, C.
    Hormann, I.
    Roscher, M.
    Moreno, J.
    Leib, O.
    Marx, S.
    Nonnenmacher, L.
    Fulda, S.
    Debatin, K.
    Miltner, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S106 - S107
  • [2] Recurrent glioblastoma multiforme - targeted alpha therapy with 213Bi-DOTA-Substance P
    Krolicki, L.
    Krolicki, B.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Jakucinski, M.
    Apostolidis, C.
    Bruchertseifer, F.
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S16 - S16
  • [3] Targeted Alpha Therapy with Bi-213
    Morgenstern, Alfred
    Bruchertseifer, Frank
    Apostolidis, Christos
    CURRENT RADIOPHARMACEUTICALS, 2011, 4 (04) : 295 - 305
  • [4] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Leszek Królicki
    Frank Bruchertseifer
    Jolanta Kunikowska
    Henryk Koziara
    Bartosz Królicki
    Maciej Jakuciński
    Dariusz Pawlak
    Christos Apostolidis
    Saed Mirzadeh
    Rafał Rola
    Adrian Merlo
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 614 - 622
  • [5] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Krolicki, Leszek
    Bruchertseifer, Frank
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Apostolidis, Christos
    Mirzadeh, Saed
    Rola, Rafal
    Merlo, Adrian
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 614 - 622
  • [6] Targeted Alpha Therapy of Glioblastoma Multiforme: Initial Clinical Experience with 213Bi-Substance P
    Morgenstern, A.
    Krolicki, L.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Mikolajczak, R.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S244 - S244
  • [7] Targeted alpha therapy of glioblastoma multiforme: First clinical experience with 213Bi-substance P
    Morgenstern, Alfred
    Krolicki, Leszek
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Apostolidis, Christos
    Bruchertseifer, Frank
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [8] Secondary glioblastoma multiforme - local alpha emiters targeted therapy with 213Bi-DOTA-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S158 - S158
  • [9] Recurrent glioblastoma multiforme - local alpha emiters targeted therapy with 213Bi-DOTA-substance P
    Krolicki, L.
    Morgenstern, A.
    Kunikowska, J.
    Koziara, H.
    Krolicki, B.
    Jakucinski, M.
    Pawlak, D.
    Apostolidis, C.
    Bruchertseifer, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S84 - S85
  • [10] Alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma multiforme
    Krolicki, Leszek
    Morgenstern, Alfred
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Apostolidis, Christos
    Bruchertseifer, Frank
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345